Sepsis Diagnostics Market in North America report 2028 | Size, Share, Growth by Business Market Insights

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America Sepsis Diagnostics Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America Sepsis Diagnostics Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 High sepsis mortality rates
5.1.2 Need for rapid diagnosis

5.2 Market Opportunities

5.2.1 Development of POC diagnostics
5.2.2 Use of biomarkers

5.3 Future Trends

5.3.1 Demand in critical care settings
5.3.2 Government initiatives for better diagnostics

5.4 Impact of Drivers and Restraints

6. North America Sepsis Diagnostics Market Regional Analysis

6.1 North America Sepsis Diagnostics Market Overview

6.2 North America Sepsis Diagnostics Market Revenue 2019-2028 (US$ Million)

6.3 North America Sepsis Diagnostics Market Forecast Analysis

7. North America Sepsis Diagnostics Market Analysis – by Product

7.1 Instruments

7.1.1 Overview
7.1.2 Instruments: North America Sepsis Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Reagents and Assays

7.2.1 Overview
7.2.2 Reagents and Assays: North America Sepsis Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Blood Culture Media

7.3.1 Overview
7.3.2 Blood Culture Media: North America Sepsis Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Software

7.4.1 Overview
7.4.2 Software: North America Sepsis Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Sepsis Diagnostics Market Analysis – by Technology

8.1 Molecular Diagnostics

8.1.1 Overview
8.1.2 Molecular Diagnostics : North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Sepsis Diagnostics Market Analysis – by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)

9. North America Sepsis Diagnostics Market – North America Analysis

9.1 North America

9.1.1 North America Sepsis Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
9.1.1.1 North America Sepsis Diagnostics Market – Revenue and Forecast Analysis – by Country
9.1.1.1 US: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.1 US: North America Sepsis Diagnostics Market Breakdown, by Product
9.1.1.1.2 US: North America Sepsis Diagnostics Market Breakdown, by Technology
9.1.1.1.3 US: North America Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)

9.1.1.2 Canada: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.1 Canada: North America Sepsis Diagnostics Market Breakdown, by Product
9.1.1.2.2 Canada: North America Sepsis Diagnostics Market Breakdown, by Technology
9.1.1.2.3 Canada: North America Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)

9.1.1.3 Mexico : North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.1 Mexico : North America Sepsis Diagnostics Market Breakdown, by Product
9.1.1.3.2 Mexico : North America Sepsis Diagnostics Market Breakdown, by Technology
9.1.1.3.3 Mexico : North America Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. North America Sepsis Diagnostics Market Industry Landscape

11.1 Overview

11.2 Mergers and Acquisitions

11.3 Agreements, Collaborations, and Joint Ventures

11.4 New Product Launches

11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 Abbott

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 BD

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 bioMerieux SA

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 Danaher (Beckman Coulter)

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 F. HOFFMANN-LA ROCHE LTD.

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

12.6 Immunexpress Inc.

12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

12.7 Luminex Corporation

12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments

12.8 T2 Biosystems, Inc.

12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments

12.9 THERMO FISHER SCIENTIFIC INC.

12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments

13. Appendix

13.1 About Business Market Insights